pharma · Total Laryngectomy · Breast Cancer · ATOS
ATOSSA THERAPEUTICS
ATOSSA THERAPEUTICS, INC.
Athos Therapeutics is a pharma organization headquartered in Torrance, USA. It trades on NYSE under ticker ATOS. Primary therapeutic focus areas include Total Laryngectomy, Breast Cancer, Breast Cancer, Preneoplastic Con
Torrance, USA HQ
2019 Founded
36 Employees
Public company Type
ATOS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Torrance, USA
- Founded
- 2019
- Employees
- 36
- Programs
- 10
- Drugs
- 5
- Patents
- 8
(Z)-endoxifen
Phase 2 · small molecule · Breast Neoplasms
(Z)-endoxifen for Breast Neoplasms is a Phase 2 program (small_molecule) at ATOSSA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Internal code ATOS-Z-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ATOSSA THERAPEUTICS, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Breast Neoplasms
- Status
- active
- Trials
- 1